Back
Plus Therapeutics, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
15
PSTV
Plus Therapeutics, Inc.
Last Price:
$0.24
Seasonality Move:
-4.04%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Plus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.27 | Sell |
| 20-day SMA: | 0.41 | Sell |
| 50-day SMA: | 0.52 | Sell |
| 200-day SMA: | 0.52 | Sell |
| 8-day EMA: | 0.06 | Buy |
| 20-day EMA: | 0.02 | Buy |
| 50-day EMA: | 0.01 | Buy |
| 200-day EMA: | 0 | Buy |
Plus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 25.45 | Sell |
| Chaikin Money Flow: | 9261776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Plus Therapeutics, Inc. Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Plus Therapeutics, Inc. Stock
Is Plus Therapeutics, Inc. Stock a Buy?
-
Plus Therapeutics, Inc. share price is 0.25 while PSTV 8-day simple moving average is 0.27, which is a Sell signal.
-
The stock price of PSTV is 0.25 while Plus Therapeutics, Inc. 20-day SMA is 0.41, which makes it a Sell.
-
Plus Therapeutics, Inc. 50-day simple moving average is 0.52 while PSTV share price is 0.25, making it a Sell technically.
-
PSTV stock price is 0.25 and Plus Therapeutics, Inc. 200-day simple moving average is 0.52, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
15
Plus Therapeutics, Inc. (PSTV)
is a Sell
Is Plus Therapeutics, Inc. a Buy or a Sell?
-
Plus Therapeutics, Inc. stock is rated a SellThe current Plus Therapeutics, Inc. [PSTV] share price is $0.25. The Score for PSTV is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics, Inc. Stock Info
Market Cap:
34.3M
Price in USD:
0.25
Share Volume:
11.3M
Plus Therapeutics, Inc. 52-Week Range
52-Week High:
2.31
52-Week Low:
0.16
Sell
15
Plus Therapeutics, Inc. (PSTV)
is a Sell
Plus Therapeutics, Inc. Share Price Forecast
-
What is the Plus Therapeutics, Inc. stock price today?The Plus Therapeutics, Inc. stock price is 0.25 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics, Inc. is overvalued.
Is Plus Therapeutics, Inc. Stock a Buy?
-
Plus Therapeutics, Inc. share price is 0.25 while PSTV 8-day exponential moving average is 0.06, which is a Buy signal.
-
The stock price of PSTV is 0.25 while Plus Therapeutics, Inc. 20-day EMA is 0.02, which makes it a Buy.
-
Plus Therapeutics, Inc. 50-day exponential moving average is 0.01 while PSTV share price is 0.25, making it a Buy technically.
-
PSTV stock price is 0.25 and Plus Therapeutics, Inc. 200-day simple moving average is 0.00, creating a Buy signal.
Fundamental Analysis of Plus Therapeutics, Inc.
Is Plus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.05 per share.
Technical Analysis of Plus Therapeutics, Inc.
Should I short Plus Therapeutics, Inc. stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Plus Therapeutics, Inc. is a Buy
-
Plus Therapeutics, Inc. Relative Strength Index (RSI) is 25.45, which suggest Plus Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Plus Therapeutics, Inc. is ( - ), which suggest Plus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Plus Therapeutics, Inc. is ( - ), which suggest Plus Therapeutics, Inc. is a Buy
* Plus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.